197 related articles for article (PubMed ID: 24832383)
1. Identification and characterization of a mirror-image oligonucleotide that binds and neutralizes sphingosine 1-phosphate, a central mediator of angiogenesis.
Purschke WG; Hoehlig K; Buchner K; Zboralski D; Schwoebel F; Vater A; Klussmann S
Biochem J; 2014 Aug; 462(1):153-62. PubMed ID: 24832383
[TBL] [Abstract][Full Text] [Related]
2. Sphingosine-1-phosphate-induced Flk-1 transactivation stimulates mouse embryonic stem cell proliferation through S1P1/S1P3-dependent β-arrestin/c-Src pathways.
Ryu JM; Baek YB; Shin MS; Park JH; Park SH; Lee JH; Han HJ
Stem Cell Res; 2014 Jan; 12(1):69-85. PubMed ID: 24145189
[TBL] [Abstract][Full Text] [Related]
3. Sphingosine kinase/sphingosine 1-phosphate (S1P)/S1P receptor axis is involved in liver fibrosis-associated angiogenesis.
Yang L; Yue S; Yang L; Liu X; Han Z; Zhang Y; Li L
J Hepatol; 2013 Jul; 59(1):114-23. PubMed ID: 23466305
[TBL] [Abstract][Full Text] [Related]
4. Involvement of sphingosine-1-phosphate and S1P1 in angiogenesis: analyses using a new S1P1 antagonist of non-sphingosine-1-phosphate analog.
Yonesu K; Kawase Y; Inoue T; Takagi N; Tsuchida J; Takuwa Y; Kumakura S; Nara F
Biochem Pharmacol; 2009 Mar; 77(6):1011-20. PubMed ID: 19150609
[TBL] [Abstract][Full Text] [Related]
5. Sphingosine 1-phosphate (S1P) receptor agonists mediate pro-fibrotic responses in normal human lung fibroblasts via S1P2 and S1P3 receptors and Smad-independent signaling.
Sobel K; Menyhart K; Killer N; Renault B; Bauer Y; Studer R; Steiner B; Bolli MH; Nayler O; Gatfield J
J Biol Chem; 2013 May; 288(21):14839-51. PubMed ID: 23589284
[TBL] [Abstract][Full Text] [Related]
6. Sphingosine-1-phosphate promotes osteogenesis by stimulating osteoblast growth and neovascularization in a vascular endothelial growth factor-dependent manner.
Wille A; Weske S; von Wnuck Lipinski K; Wollnitzke P; Schröder NH; Thomas N; Nowak MK; Deister-Jonas J; Behr B; Keul P; Levkau B
J Bone Miner Res; 2024 Apr; 39(3):357-372. PubMed ID: 38477738
[TBL] [Abstract][Full Text] [Related]
7. Sphingosine kinase 1/sphingosine 1-phosphate/sphingosine 1-phosphate receptor 1 pathway: A novel target of geniposide to inhibit angiogenesis.
Sun M; Deng R; Wang Y; Wu H; Zhang Z; Bu Y; Zhang H
Life Sci; 2020 Sep; 256():117988. PubMed ID: 32569777
[TBL] [Abstract][Full Text] [Related]
8. Sphingosine-1-phosphate promotes the proliferation and attenuates apoptosis of Endothelial progenitor cells via S1PR1/S1PR3/PI3K/Akt pathway.
Wang H; Huang H; Ding SF
Cell Biol Int; 2018 Nov; 42(11):1492-1502. PubMed ID: 29790626
[TBL] [Abstract][Full Text] [Related]
9. Sphingosine-1-phosphate (S1P) displays sustained S1P1 receptor agonism and signaling through S1P lyase-dependent receptor recycling.
Gatfield J; Monnier L; Studer R; Bolli MH; Steiner B; Nayler O
Cell Signal; 2014 Jul; 26(7):1576-88. PubMed ID: 24704119
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia augments outgrowth endothelial cell (OEC) sprouting and directed migration in response to sphingosine-1-phosphate (S1P).
Williams PA; Stilhano RS; To VP; Tran L; Wong K; Silva EA
PLoS One; 2015; 10(4):e0123437. PubMed ID: 25875493
[TBL] [Abstract][Full Text] [Related]
11. Ginsenoside compound K inhibits angiogenesis via regulation of sphingosine kinase-1 in human umbilical vein endothelial cells.
Shin KO; Seo CH; Cho HH; Oh S; Hong SP; Yoo HS; Hong JT; Oh KW; Lee YM
Arch Pharm Res; 2014; 37(9):1183-92. PubMed ID: 24687256
[TBL] [Abstract][Full Text] [Related]
12. Reassessment of the pharmacology of Sphingosine-1-phosphate S1P3 receptor ligands using the DiscoveRx PathHunter™ and Ca2+ release functional assays.
Riddy DM; Stamp C; Sykes DA; Charlton SJ; Dowling MR
Br J Pharmacol; 2012 Oct; 167(4):868-80. PubMed ID: 22577868
[TBL] [Abstract][Full Text] [Related]
13. Induction of endothelial cell chemotaxis by sphingosine 1-phosphate and stabilization of endothelial monolayer barrier function by lysophosphatidic acid, potential mediators of hematopoietic angiogenesis.
English D; Kovala AT; Welch Z; Harvey KA; Siddiqui RA; Brindley DN; Garcia JG
J Hematother Stem Cell Res; 1999 Dec; 8(6):627-34. PubMed ID: 10645770
[TBL] [Abstract][Full Text] [Related]
14. Blocking S1P interaction with S1P₁ receptor by a novel competitive S1P₁-selective antagonist inhibits angiogenesis.
Fujii Y; Ueda Y; Ohtake H; Ono N; Takayama T; Nakazawa K; Igarashi Y; Goitsuka R
Biochem Biophys Res Commun; 2012 Mar; 419(4):754-60. PubMed ID: 22387544
[TBL] [Abstract][Full Text] [Related]
15. Bioactive lipids S1P and C1P are prometastatic factors in human rhabdomyosarcoma, and their tissue levels increase in response to radio/chemotherapy.
Schneider G; Bryndza E; Abdel-Latif A; Ratajczak J; Maj M; Tarnowski M; Klyachkin YM; Houghton P; Morris AJ; Vater A; Klussmann S; Kucia M; Ratajczak MZ
Mol Cancer Res; 2013 Jul; 11(7):793-807. PubMed ID: 23615526
[TBL] [Abstract][Full Text] [Related]
16. Anti-sphingosine-1-phosphate monoclonal antibodies inhibit angiogenesis and sub-retinal fibrosis in a murine model of laser-induced choroidal neovascularization.
Caballero S; Swaney J; Moreno K; Afzal A; Kielczewski J; Stoller G; Cavalli A; Garland W; Hansen G; Sabbadini R; Grant MB
Exp Eye Res; 2009 Mar; 88(3):367-77. PubMed ID: 18723015
[TBL] [Abstract][Full Text] [Related]
17. Sphingosine signalling regulates decidual NK cell angiogenic phenotype and trophoblast migration.
Zhang J; Dunk CE; Lye SJ
Hum Reprod; 2013 Nov; 28(11):3026-37. PubMed ID: 24001716
[TBL] [Abstract][Full Text] [Related]
18. Novel implications for lysophospholipids, lysophosphatidic acid and sphingosine 1-phosphate, as drug targets in cancer.
Peyruchaud O
Anticancer Agents Med Chem; 2009 May; 9(4):381-91. PubMed ID: 19442039
[TBL] [Abstract][Full Text] [Related]
19. A metabolic shift favoring sphingosine 1-phosphate at the expense of ceramide controls glioblastoma angiogenesis.
Abuhusain HJ; Matin A; Qiao Q; Shen H; Kain N; Day BW; Stringer BW; Daniels B; Laaksonen MA; Teo C; McDonald KL; Don AS
J Biol Chem; 2013 Dec; 288(52):37355-64. PubMed ID: 24265321
[TBL] [Abstract][Full Text] [Related]
20. Investigating the molecular mechanisms through which FTY720-P causes persistent S1P1 receptor internalization.
Sykes DA; Riddy DM; Stamp C; Bradley ME; McGuiness N; Sattikar A; Guerini D; Rodrigues I; Glaenzel A; Dowling MR; Mullershausen F; Charlton SJ
Br J Pharmacol; 2014 Nov; 171(21):4797-807. PubMed ID: 24641481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
